Suspension for injection
The vaccine contains inactivated porcine rotavirus, serogroup A, selected serovars of inactivated enterotoxigenic E. coli strains, pathogenic for suckling piglets, containing F4ac, F5, F41 and F6 fimbria adhesins and also toxoid β (sensu lato) Clostridium perfringens, type C (produces a‑ and β1‑, β2‑toxin).
Each dose (2 ml) contains:
| Porcine rotavirus, serogroup A, strain OSU 6, inactivated
Escherichia coli, serotype O149:K88 (F4ac), inactivated Escherichia coli, serotype O101:K99 (F5 and F41), inactivated Escherichia coli, serotype K85:987P (F6), inactivated Clostridium perfringens, type C, beta toxoid |
RP ≥ 1*
RP ≥ 1* RP ≥ 1* (F5), RP ≥ 1* (F41) RP ≥ 1* RP ≥ 1*, ** |
F = fimbrial adhesin
* RP = Relative potency (ELISA), in comparison with reference serum obtained from vaccinated mice with vaccine batch, which complied in challenge test on target species.
** minimal listed value complies with potency ≥ 20 IU required by Ph. Eur.
Montanide ISA 35 VG 0.52 ml
Pigs (pregnant gilts and sows)
